SI3368544T1 - Peptidni makrocikli proti Acinetobacter baumannii - Google Patents
Peptidni makrocikli proti Acinetobacter baumanniiInfo
- Publication number
- SI3368544T1 SI3368544T1 SI201630882T SI201630882T SI3368544T1 SI 3368544 T1 SI3368544 T1 SI 3368544T1 SI 201630882 T SI201630882 T SI 201630882T SI 201630882 T SI201630882 T SI 201630882T SI 3368544 T1 SI3368544 T1 SI 3368544T1
- Authority
- SI
- Slovenia
- Prior art keywords
- acinetobacter baumannii
- against acinetobacter
- peptide macrocycles
- macrocycles against
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15191743 | 2015-10-27 | ||
| CN2016100125 | 2016-09-26 | ||
| PCT/EP2016/075499 WO2017072062A1 (en) | 2015-10-27 | 2016-10-24 | Peptide macrocycles against acinetobacter baumannii |
| EP16785469.4A EP3368544B1 (en) | 2015-10-27 | 2016-10-24 | Peptide macrocycles against acinetobacter baumannii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3368544T1 true SI3368544T1 (sl) | 2020-10-30 |
Family
ID=57200005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201630882T SI3368544T1 (sl) | 2015-10-27 | 2016-10-24 | Peptidni makrocikli proti Acinetobacter baumannii |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US10030047B2 (sl) |
| EP (1) | EP3368544B1 (sl) |
| JP (2) | JP7286317B2 (sl) |
| KR (1) | KR20180063138A (sl) |
| CN (1) | CN108350028B (sl) |
| AU (1) | AU2016347456B2 (sl) |
| CA (1) | CA2992926A1 (sl) |
| CL (1) | CL2018000978A1 (sl) |
| CO (1) | CO2017013708A2 (sl) |
| CR (1) | CR20180232A (sl) |
| DK (1) | DK3368544T3 (sl) |
| ES (1) | ES2811911T3 (sl) |
| HK (1) | HK1258443A1 (sl) |
| HR (1) | HRP20201273T1 (sl) |
| HU (1) | HUE050053T2 (sl) |
| IL (1) | IL258060B (sl) |
| MX (2) | MX2018005236A (sl) |
| MY (1) | MY193014A (sl) |
| PE (1) | PE20180796A1 (sl) |
| PH (1) | PH12018500904A1 (sl) |
| PL (1) | PL3368544T3 (sl) |
| PT (1) | PT3368544T (sl) |
| RS (1) | RS60662B1 (sl) |
| RU (1) | RU2729609C2 (sl) |
| SI (1) | SI3368544T1 (sl) |
| TW (1) | TWI720042B (sl) |
| UA (1) | UA124303C2 (sl) |
| WO (1) | WO2017072062A1 (sl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2957836C (en) * | 2014-08-13 | 2019-06-25 | Huawei Technologies Co., Ltd. | Fbmc signal transmitting method and receiving method, transmitter and receiver |
| BR112019010294A2 (pt) | 2016-12-21 | 2019-09-03 | Hoffmann La Roche | método para a produção enzimática de um anticorpo, anticorpo e formulação farmacêutica |
| EP3388444A1 (en) * | 2017-04-10 | 2018-10-17 | F. Hoffmann-La Roche AG | Anti-bacterial peptide macrocycles and use thereof |
| US11505573B2 (en) * | 2018-03-28 | 2022-11-22 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
| US11819532B2 (en) * | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
| JP2022513851A (ja) * | 2018-12-17 | 2022-02-09 | エフ．ホフマン－ラ ロシュ アーゲー | 抗菌剤としてのイミダゾピラジン誘導体 |
| EP3934756A1 (en) | 2019-03-08 | 2022-01-12 | F. Hoffmann-La Roche AG | Novel imidazole-pyrazole derivatives |
| WO2021148420A1 (en) | 2020-01-22 | 2021-07-29 | F. Hoffmann-La Roche Ag | Novel heterocyclic compounds |
| CN115485279A (zh) | 2020-04-29 | 2022-12-16 | 豪夫迈·罗氏有限公司 | 抗菌8-苯基氨基-3-(吡唑-4-基)咪唑并[1,2-a]吡嗪衍生物 |
| EP4157846A1 (en) | 2020-06-01 | 2023-04-05 | F. Hoffmann-La Roche AG | Novel imidazopyrazne derivatives |
| WO2021249893A1 (en) | 2020-06-08 | 2021-12-16 | F. Hoffmann-La Roche Ag | Novel imidazo-pyrazine derivatives |
| EP4161931A1 (en) | 2020-06-09 | 2023-04-12 | F. Hoffmann-La Roche AG | Novel imidazopyrazine derivatives |
| JP2023538969A (ja) | 2020-08-31 | 2023-09-12 | エフ． ホフマン－ラ ロシュ アーゲー | 抗菌薬としてのイミダゾール－ピラゾール誘導体 |
| JP2023540307A (ja) | 2020-09-01 | 2023-09-22 | エフ． ホフマン－ラ ロシュ アーゲー | 抗菌特性を有するイミダゾール－ピラゾール誘導体 |
| CN116096709A (zh) | 2020-09-07 | 2023-05-09 | 豪夫迈·罗氏有限公司 | 新型杂环抗生素 |
| EP4288424A1 (en) | 2021-02-07 | 2023-12-13 | F. Hoffmann-La Roche AG | Novel heteroaryl-substituted imidazole derivatives |
| WO2023280733A1 (en) | 2021-07-06 | 2023-01-12 | F. Hoffmann-La Roche Ag | Quaternary ammonium cation substituted compounds for the treatment of bacterial infections |
| WO2023285497A1 (en) | 2021-07-15 | 2023-01-19 | F. Hoffmann-La Roche Ag | Imidazole derivatives and their use as antibiotics |
| WO2023161316A1 (en) | 2022-02-25 | 2023-08-31 | F. Hoffmann-La Roche Ag | Zwitterionic antibacterial compounds |
| WO2024033278A1 (en) * | 2022-08-09 | 2024-02-15 | F. Hoffmann-La Roche Ag | Process for manufacturing an antibiotic macrocyclic peptide |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6660832B1 (en) * | 1999-08-20 | 2003-12-09 | Isis Pharmaceuticals, Inc. | Macrocyclic compounds and preparation methods thereof |
| DE10226921A1 (de) | 2002-06-17 | 2003-12-24 | Bayer Ag | Antibakterielle Amid-Makrozyklen |
| RU2311415C2 (ru) * | 2002-08-23 | 2007-11-27 | Слоан-Кеттеринг Инститьют Фор Кэнсер Рисерч | Синтез эпотилонов, их промежуточных продуктов, аналогов и их применения |
| AU2003260002B2 (en) | 2002-08-23 | 2010-03-18 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US7491695B2 (en) | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| DK1633774T3 (da) | 2003-06-18 | 2010-05-25 | Tranzyme Pharma Inc | Makrocykliske motilinreceptorantagonister |
| EP1498422A1 (de) | 2003-07-17 | 2005-01-19 | Jerini AG | C5a-Rezeptor-Antagonisten |
| WO2005012332A1 (en) | 2003-07-31 | 2005-02-10 | Tranzyme Pharma | Spatially-defined macrocycles incorporating peptide bond surrogates |
| SI1648922T1 (sl) | 2003-07-31 | 2011-03-31 | Tranzyme Pharma Inc | Prostorsko opredeljene makrocikliäśne spojine uporabne za odkrivanje zdravil |
| WO2005033129A1 (de) | 2003-10-01 | 2005-04-14 | Bayer Healthcare Ag | Antibakterielle amid-makrozyklen |
| WO2005090388A1 (en) | 2004-03-19 | 2005-09-29 | The University Of Queensland | Alpha helical mimics, their uses and methods for their production |
| DE102004025731A1 (de) * | 2004-05-26 | 2005-12-15 | Bayer Healthcare Ag | Antibakterielle Amid-Makrozyklen III |
| CN101107264A (zh) | 2005-01-17 | 2008-01-16 | 捷瑞尼股份公司 | C5a受体拮抗剂 |
| GB0609492D0 (en) | 2006-05-15 | 2006-06-21 | Angeletti P Ist Richerche Bio | Therapeutic agents |
| CN105254637A (zh) | 2007-02-08 | 2016-01-20 | 爱尔兰詹森科学公司 | 嘧啶取代的大环抑制剂 |
| WO2009099677A2 (en) | 2008-02-08 | 2009-08-13 | Aileron Therapeutics, Inc. | Therapeutic peptidomimetic macrocycles |
| EP2350031A2 (en) | 2008-08-20 | 2011-08-03 | Ensemble Therapeutics Corporation | Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| US20120270807A1 (en) | 2009-10-23 | 2012-10-25 | Marsault Eric | Macrocyclic inhibitors of serine protease enzymes |
| JP2013509434A (ja) | 2009-10-30 | 2013-03-14 | トランザイム・ファーマ，インコーポレイテッド | 大環状グレリン受容体アンタゴニストおよびインバースアゴニストならびにその使用方法 |
| EP2603600B1 (en) | 2010-08-13 | 2018-11-21 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| AU2012301605A1 (en) | 2011-08-31 | 2014-04-17 | New York University | Thioether-,ether-, and alkylamine-linked hydrogen bond surrogate pertidomimentics |
| WO2013123266A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CN103387601B (zh) | 2012-05-11 | 2017-01-11 | 南开大学 | 抗登革热病毒(denv)杂环肽类化合物及其制备方法和用途 |
| EP2922829B1 (en) | 2012-11-21 | 2021-08-11 | RQX Pharmaceuticals, Inc. | Macrocyclic broad spectrum antibiotics |
| WO2014110420A1 (en) | 2013-01-10 | 2014-07-17 | Noliva Therapeutics Llc | Peptidomimetic compounds |
| EP3388444A1 (en) | 2017-04-10 | 2018-10-17 | F. Hoffmann-La Roche AG | Anti-bacterial peptide macrocycles and use thereof |
| US11505573B2 (en) | 2018-03-28 | 2022-11-22 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
| US11819532B2 (en) | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
-
2016
- 2016-10-24 RU RU2018113426A patent/RU2729609C2/ru active
- 2016-10-24 AU AU2016347456A patent/AU2016347456B2/en active Active
- 2016-10-24 RS RS20200964A patent/RS60662B1/sr unknown
- 2016-10-24 UA UAA201805849A patent/UA124303C2/uk unknown
- 2016-10-24 CN CN201680062428.6A patent/CN108350028B/zh active Active
- 2016-10-24 PE PE2018000242A patent/PE20180796A1/es unknown
- 2016-10-24 SI SI201630882T patent/SI3368544T1/sl unknown
- 2016-10-24 EP EP16785469.4A patent/EP3368544B1/en active Active
- 2016-10-24 HU HUE16785469A patent/HUE050053T2/hu unknown
- 2016-10-24 MY MYPI2018701615A patent/MY193014A/en unknown
- 2016-10-24 JP JP2018521507A patent/JP7286317B2/ja active Active
- 2016-10-24 CR CR20180232A patent/CR20180232A/es unknown
- 2016-10-24 PL PL16785469T patent/PL3368544T3/pl unknown
- 2016-10-24 MX MX2018005236A patent/MX2018005236A/es unknown
- 2016-10-24 CA CA2992926A patent/CA2992926A1/en active Pending
- 2016-10-24 PT PT167854694T patent/PT3368544T/pt unknown
- 2016-10-24 DK DK16785469.4T patent/DK3368544T3/da active
- 2016-10-24 WO PCT/EP2016/075499 patent/WO2017072062A1/en active Application Filing
- 2016-10-24 KR KR1020187010641A patent/KR20180063138A/ko not_active Application Discontinuation
- 2016-10-24 ES ES16785469T patent/ES2811911T3/es active Active
- 2016-10-26 TW TW105134492A patent/TWI720042B/zh active
- 2016-10-27 US US15/336,128 patent/US10030047B2/en active Active
-
2017
- 2017-12-28 CO CONC2017/0013708A patent/CO2017013708A2/es unknown
-
2018
- 2018-03-13 IL IL258060A patent/IL258060B/en active IP Right Grant
- 2018-04-16 CL CL2018000978A patent/CL2018000978A1/es unknown
- 2018-04-26 MX MX2022010520A patent/MX2022010520A/es unknown
- 2018-04-26 PH PH12018500904A patent/PH12018500904A1/en unknown
- 2018-06-12 US US16/006,564 patent/US11098080B2/en active Active
-
2019
- 2019-01-15 HK HK19100675.1A patent/HK1258443A1/zh unknown
-
2020
- 2020-08-13 HR HRP20201273TT patent/HRP20201273T1/hr unknown
-
2021
- 2021-07-15 US US17/377,338 patent/US20220411468A1/en active Pending
- 2021-11-09 JP JP2021182289A patent/JP2022024009A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1258443A1 (zh) | 對抗鮑曼不動桿菌(acinetobacter baumannii)的肽大環 | |
| IL278053A (en) | Macrocyclic peptide against Acinetobacter baumannii | |
| IL257706A (en) | Peptidomimetic macrocycles and their uses | |
| IL254444A0 (en) | Peptidomimetic macrocycles and their uses | |
| GB201520559D0 (en) | Peptides | |
| GB201520536D0 (en) | Peptides | |
| GB201520546D0 (en) | Peptides | |
| GB201520545D0 (en) | Peptides | |
| GB201520562D0 (en) | Peptides | |
| GB201520543D0 (en) | Peptides | |
| GB201520541D0 (en) | Peptides | |
| GB201520550D0 (en) | Peptides | |
| GB201520539D0 (en) | Peptides | |
| GB201520563D0 (en) | Peptides | |
| GB201520544D0 (en) | Peptides | |
| ZA201804225B (en) | Piston-chamber combination | |
| GB201520542D0 (en) | Peptides | |
| GB201520558D0 (en) | Peptides | |
| GB201520548D0 (en) | Peptides | |
| GB201520557D0 (en) | Peptides | |
| ZA201708653B (en) | Peptide macrocycles against acinetobacter baumannii | |
| LT3368544T (lt) | Peptidų makrociklai prieš acinetobacter baumannii | |
| GB201520561D0 (en) | Peptides | |
| GB201520555D0 (en) | Peptides | |
| GB201520547D0 (en) | Peptides |